Loading, please wait....jpg)
.jpg)
CONTINUING PHARMACY EDUCATION
Optimizing Use of Novel Agents to Treat Multidrug-resistant Gram-negative Infections
Speaker:
Ryan K. Shields, PharmD, MS, Co-Director, Antibiotic Management Program, University of Pittsburgh, Pittsburgh, PA
ACPE Universal Program ID# 0122-0000-23-019-H01-P/T
1 Contact Hours [0.1 CEU]
Release Date: January 17, 2023
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists and Pharmacy Technicians
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
There are 2 steps to completing this home-study CE.
Step 1: Watch the video presentation in its entirety.
Step 2: Click on "Take the Test" to complete the post-test and evaluation.
Please Note: A handout is provided. Please print it out and follow along with the audio recording.
Objectives
- Identify the serious and urgent MDR Gram-negative threats in the United States
- Define the spectrum of in vitro activity for novel beta-lactam agents
- List the most common mechanisms of beta-lactam resistance
- Review treatment guidelines for MDR Gram-negative infections
Speaker(s)/Author(s)
|
Ryan K. Shields, Pharm D, MS
|
Activity Number
0122-0000-23-019-H01-P/T
Release Date:
Jan 17, 2023
Credit Expiration Date:
Jan 17, 2026
CE Hours
1.00